ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Natera Inc

Natera Inc (NTRA)

168.45
0.13
(0.08%)
Closed November 28 4:00PM
168.011
-0.439
(-0.26%)
After Hours: 7:50PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
168.011
Bid
160.05
Ask
168.45
Volume
925,944
166.58 Day's Range 170.935
53.8801 52 Week Range 171.9499
Market Cap
Previous Close
168.32
Open
170.295
Last Trade
1
@
167
Last Trade Time
Financial Volume
$ 155,795,754
VWAP
168.2561
Average Volume (3m)
1,250,356
Shares Outstanding
132,020,816
Dividend Yield
-
PE Ratio
-51.17
Earnings Per Share (EPS)
-3.29
Revenue
1.08B
Net Profit
-434.8M

About Natera Inc

Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing the genetic features of a fetus. Natera's array of diagnostic services includes Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of... Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing the genetic features of a fetus. Natera's array of diagnostic services includes Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic, or a patient for the test upon delivery of the test result. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Natera Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker NTRA. The last closing price for Natera was $168.32. Over the last year, Natera shares have traded in a share price range of $ 53.8801 to $ 171.9499.

Natera currently has 132,020,816 shares outstanding. The market capitalization of Natera is $22.22 billion. Natera has a price to earnings ratio (PE ratio) of -51.17.

Natera (NTRA) Options Flow Summary

Overall Flow

Bearish

Net Premium

-3M

Calls / Puts

150.00%

Buys / Sells

300.00%

OTM / ITM

66.67%

Sweeps Ratio

0.00%

NTRA Latest News

Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its Prospera Lung test has met coverage requirements from the Centers for Medicare &...

Natera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer Symposium

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will present new SignateraTM data at the San Antonio Breast Cancer Symposium (SABCS...

Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™

Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant...

Natera Issues Statement on Guardant Health Litigation

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today issued the following statement: In 2021, Natera and Guardant Health filed false advertising cases against...

Natera Co-Founder and Executive Chairman Matthew Rabinowitz Named 2024 R&D Leader of the Year

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its co-founder and executive chairman, Matthew Rabinowitz, PhD, has been named R&D...

Natera Announces Publication of over 100 Peer-Reviewed Papers on SignateraTM

Underscores the Company’s commitment to generating robust scientific evidence on its leading MRD technology Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
14.2512.59587200782163.76171.9499160.181562399167.14568434CS
445.22136.8279175829122.79171.9499120.671655157149.73638553CS
1255.00148.6691443235113.01171.9499110.571250356136.17235611CS
2658.01152.7372727273110171.949992.141304392121.86266764CS
52113.551208.50348879954.46171.949953.8801135871999.65136793CS
15672.24175.431763600395.77171.949926.1141490164.01034008CS
260129.571337.07336108238.44171.949916.87118110867.80029928CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VCIGVCI Global Ltd
$ 4.1092
(129.56%)
257.18M
IDAIT Stamp Inc
$ 0.835
(128.77%)
369.69M
WAITop KingWin Ltd
$ 0.43
(79.17%)
121.91M
HWHHWH International Inc
$ 0.918
(62.48%)
32.06M
PROCProcaps Group SA
$ 2.149
(58.01%)
210.26k
PGHLPrimega Group Holdings Ltd
$ 1.6455
(-98.47%)
43.2M
OTLKOutlook Therapeutics Inc
$ 1.695
(-65.34%)
61.98M
IMGCIMG Inc
$ 0.8831
(-44.81%)
5.22M
KDLYKindly MD Inc
$ 1.075
(-43.12%)
3.54M
HAOHaoxi Health Technology Ltd
$ 0.13
(-36.59%)
36.86M
IDAIT Stamp Inc
$ 0.835
(128.77%)
374.4M
VCIGVCI Global Ltd
$ 4.1092
(129.56%)
257.58M
NVDANVIDIA Corporation
$ 135.34
(-1.15%)
226.41M
WAITop KingWin Ltd
$ 0.43
(79.17%)
121.92M
MARAMARA Holdings Inc
$ 26.915
(7.79%)
87.94M

Your Recent History

Delayed Upgrade Clock